CHARLES SCHWAB INVESTMENT MANAGEMENT INC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 1 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,591,000
-15.5%
30,113
-1.9%
0.00%0.0%
Q2 2020$1,882,000
+14.2%
30,704
+5.4%
0.00%0.0%
Q1 2020$1,648,000
-46.5%
29,118
-46.2%
0.00%
-50.0%
Q4 2019$3,083,000
+18.5%
54,134
+11.4%
0.00%0.0%
Q3 2019$2,601,000
+3.4%
48,593
+15.4%
0.00%0.0%
Q2 2019$2,515,000
-0.9%
42,117
+3.4%
0.00%0.0%
Q1 2019$2,539,000
-9.4%
40,728
-11.9%
0.00%0.0%
Q4 2018$2,803,000
+3.6%
46,2440.0%0.00%0.0%
Q3 2018$2,705,000
+29.9%
46,244
-0.4%
0.00%0.0%
Q2 2018$2,083,000
+9.5%
46,426
+8.2%
0.00%
+100.0%
Q1 2018$1,903,000
+2.3%
42,9120.0%0.00%0.0%
Q4 2017$1,860,000
-4.4%
42,912
+2.6%
0.00%
-50.0%
Q3 2017$1,946,000
+2.7%
41,812
+9.3%
0.00%0.0%
Q2 2017$1,895,000
-9.7%
38,2710.0%0.00%0.0%
Q1 2017$2,098,000
-12.4%
38,271
-11.0%
0.00%
-33.3%
Q4 2016$2,396,000
+17.3%
43,010
-3.8%
0.00%
+50.0%
Q3 2016$2,042,000
+14.3%
44,7100.0%0.00%0.0%
Q2 2016$1,786,000
+14.7%
44,7100.0%0.00%0.0%
Q1 2016$1,557,000
-19.0%
44,7100.0%0.00%
-33.3%
Q4 2015$1,922,000
-1.3%
44,7100.0%0.00%0.0%
Q3 2015$1,947,000
-10.2%
44,710
+6.4%
0.00%0.0%
Q2 2015$2,168,000
+12.0%
42,010
-15.0%
0.00%0.0%
Q1 2015$1,935,000
+1.4%
49,4150.0%0.00%0.0%
Q4 2014$1,909,000
+9.4%
49,4150.0%0.00%0.0%
Q3 2014$1,745,000
+55.8%
49,415
+19.0%
0.00%
+50.0%
Q2 2014$1,120,00041,5400.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2020
NameSharesValueWeighting ↓
UBS ASSET MANAGEMENT AMERICAS INC 2,300$203,550,0000.00%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders